Moderna applies for a second booster dose of COVID-19 vaccine for adults in the US

Application for license Second booster vaccine (fourth dose of vaccine) of Moderna has a broader scope than the request from pharmaceutical company Pfizer earlier this week, which proposed that US regulators approve a booster vaccine for the elderly.

In a press release, Moderna said the request to approve a fourth dose of the vaccine for all adults was made “to give flexibility” to the US Centers for Disease Control and Prevention (CDC) and healthcare providers in determining the “appropriate use” of a second booster dose of mRNA vaccine, “including those at increased risk for COVID-19 due to age or comorbidities “.

American officials have laid the basis for providing additional injections to enhance vaccine protection against severe disease progression and death from COVID-19. The White House has sounded the alarm that it needs the US Congress “urgently” to approve more funding for the federal government to ensure more COVID-19 vaccine stocks, or for additional doses or prevention. for specific variations.

Moderna’s COVID-19 vaccine. (Image: Getty Images)

U.S. health officials currently recommend a basic vaccination schedule consisting of two doses of Moderna vaccine and a booster dose several months later.

Moderna said its request for an additional dose of the vaccine is based on “recently published data generated in the US and Israel following the emergence of Omicron variant“.

On March 15, Pfizer and partner BioNTech applied for a license to add a booster dose of COVID-19 vaccine for the elderly in the US, saying data from Israel shows that elderly people will benefit from this booster vaccine.

* Invite readers to watch programs broadcast by Vietnam Television on TV Online and VTVGo!